- BLUE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
bluebird bio (BLUE) 8-K21 May 21SKYSONA is the first and only gene therapy recommended for approval for patients with CALD, a progressive, neurodegenerative diseaseFinancial data
Company Profile